Effect of IL-15 and natural killer cells on osteoclasts and osteoblasts in a mouse coculture

Inflammation

Volumn 37, Issue 3, 2014, Pages 657-669

  Takeda, Hiroaki ^a   Kikuchi, Takeshi ^a   Soboku, Kyoko ^a   Okabe, Iichiro ^a   Mizutani, Hiroki ^a   Mitani, Akio ^a   Ishihara, Yuichi ^a   Noguchi, Toshihide ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

apoptosis; bone metabolism; inflammation; osteoblast; osteoclast

Indexed keywords

ALKALINE PHOSPHATASE; CASPASE 3; INTERLEUKIN 15; PROSTAGLANDIN E2;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; BONE METABOLISM; BONE MINERALIZATION; CALCIFICATION; CELL DIFFERENTIATION; CELL ISOLATION; CELL STIMULATION; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; NATURAL KILLER CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; PERIODONTAL DISEASE; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; ANIMAL; BIOSYNTHESIS; BONE; BONE DEVELOPMENT; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; MOUSE; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; ARTHRITIS, RHEUMATOID; BONE AND BONES; BONE DEVELOPMENT; BONE MARROW CELLS; CASPASE 3; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DINOPROSTONE; INTERLEUKIN-15; KILLER CELLS, NATURAL; MICE; OSTEOBLASTS; OSTEOCLASTS; PERIODONTAL DISEASES; T-LYMPHOCYTES;

EID: 84902543388     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9782-0     Document Type: Article

References (41)

1. Matei, I., and L. Matei. 2002. Cytokine patterns and pathogenicity in autoimmune diseases. Romanian Journal of Internal Medicine 40: 27-41.
2. Reinhardt, R.A., M.P. Masada, W.B. Kaldahl, L.M. DuBois, K.S. Kornman, J.I. Choi, et al. 1993. Gingival fluid IL-1 and IL-6 levels in refractory periodontitis. Journal of Clinical Periodontology 20: 225-231.
3. Rossomando, E.F., J.E. Kennedy, and J. Hadjimichael. 1990. Tumour necrosis factor alpha in gingival crevicular fluid as a possible indicator of periodontal disease in humans. Archives of Oral Biology 35: 431-434.
4. Katagiri, T., and N. Takahashi. 2002. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Diseases 8: 147-159. (Pubitemid 34535063)
5. McInnes, I.B., J. al-Mughales, M. Field, B.P. Leung, F.P. Huang, R. Dixon, et al. 1996. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nature Medicine 2: 175-182. (Pubitemid 26057554)
6. Tymkiw, K.D., D.H. Thunell, G.K. Johnson, S. Joly, K.K. Burnell, J.E. Cavanaugh, et al. 2011. Influence of smoking on gingival crevicular fluid cytokines in severe chronic periodontitis. Journal of Clinical Periodontology 38: 219-228.
7. Thurkow, E.W., I.M. van der Heijden, F.C. Breedveld, T.J. Smeets, M.R. Daha, P.M. Kluin, et al. 1997. Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. The Journal of Pathology 181: 444-450.
8. Burton, J.D., R.N. Bamford, C. Peters, A.J. Grant, G. Kurys, C.K. Goldman, et al. 1994. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proceedings of the National Academy of Sciences of the United States of America 91: 4935-4939. (Pubitemid 24177765)
9. Grabstein, K.H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, et al. 1994. Cloning of a Tcell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264: 965-968. (Pubitemid 24196167)
10. Carson, W.E., J.G. Giri, M.J. Lindemann, M.L. Linett, M. Ahdieh, R. Paxton, et al. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. The Journal of Experimental Medicine 180: 1395-1403. (Pubitemid 24289613)
11. Armitage, R.J., B.M. Macduff, J. Eisenman, R. Paxton, and K.H. Grabstein. 1995. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. The Journal of Immunology 154: 483-490.
12. Mitani, A., H. Nishimura, K. Hirose, J. Washizu, Y. Kimura, S. Tanaka, et al. 1999. Interleukin-15 production at the early stage after oral infection with Listeria monocytogenes in mice. Immunology 97: 92-99. (Pubitemid 29217265)
13. Buduneli, E., F. Genel, G. Atilla, and N. Kutukculer. 2003. Evaluation of p53, bcl-2, and interleukin-15 levels in gingival crevicular fluid of cyclosporin A-treated patients. The Journal of Periodontology 74: 506-511. (Pubitemid 36559487)
14. Andersson, A.K., M. Feldmann, and F.M. Brennan. 2008. Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis. Scandinavian Journal of Immunology 68: 103-111. (Pubitemid 351798402)
15. Ogata, Y., A. Kukita, T. Kukita, M. Komine, A. Miyahara, S. Miyazaki, et al. 1999. A novel role of IL-15 in the development of osteoclasts: inability to replace its activity with IL-2. The Journal of Immunology 162: 2754-2760. (Pubitemid 29309299)
16. Ferrari-Lacraz, S., E. Zanelli, M. Neuberg, E. Donskoy, Y.S. Kim, X.X. Zheng, et al. 2004. Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis. The Journal of Immunology 173: 5818-5826. (Pubitemid 39392172)
17. Miranda-Carus, M.E., M. Benito-Miguel, A. Balsa, T. Cobo-Ibanez, C. Perez de Ayala, D. Pascual-Salcedo, et al. 2006. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes. Arthritis and Rheumatism 54: 1151-1164. (Pubitemid 43672928)
18. Djaafar, S., D.D. Pierroz, R. Chicheportiche, X.X. Zheng, S.L. Ferrari, and S. Ferrari-Lacraz. 2010. Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice. Arthritis and Rheumatism 62: 3300-3310.
19. Suda, T., E. Jimi, I. Nakamura, and N. Takahashi. 1997. Role of 1 alpha,25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods in Enzymology 282: 223-235. (Pubitemid 27412778)
20. Noguchi, K., M. Yanai, M. Shitashige, T. Nishihara, and I. Ishikawa. 2000. Cyclooxygenase-2-dependent prostaglandin production by peripheral bloodmonocytes stimulatedwith lipopolysaccharides isolated from periodontopathogenic bacteria. The Journal of Periodontology 71: 1575-1582.
21. Yucel-Lindberg, T., H. Ahola, J. Carlstedt-Duke, and T. Modeer. 1999. Involvement of tyrosine kinases on cyclooxygenase expression and prostaglandin E2 production in human gingival fibroblasts stimulated with interleukin-1beta and epidermal growth factor. Biochemical and Biophysical Research Communications 257: 528-532. (Pubitemid 29301476)
22. Hughes, F.J., L.D. Buttery, M.V. Hukkanen, A. O'Donnell, J. Maclouf, and J.M. Polak. 1999. Cytokine-induced prostaglandin E2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and -independentmechanismin rat osteoblasts in vitro. The Journal of Biological Chemistry 274: 1776-1782.
23. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, et al. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proceedings of the National Academy of Sciences of the United States of America 95: 3597-3602.
24. Nagata, T., K. Kaho, S. Nishikawa, H. Shinohara, Y. Wakano, and H. Ishida. 1994. Effect of prostaglandin E2 on mineralization of bone nodules formed by fetal rat calvarial cells. Calcified Tissue International 55: 451-457. (Pubitemid 24370994)
25. Jimi, E., T. Ikebe, N. Takahashi, M. Hirata, T. Suda, and T. Koga. 1996. Interleukin-1 alpha activates an NF-kappaB-like factor in osteoclast-like cells. The Journal of Biological Chemistry 271: 4605-4608.
26. Fuster, G., V. Almendro, C.C. Fontes-Oliveira, M. Toledo, P. Costelli, S. Busquets, et al. 2011. Interleukin-15 affects differentiation and apoptosis in adipocytes: implications in obesity. Lipids 46: 1033-1042.
27. Tsuboi, M., A. Kawakami, T. Nakashima, N. Matsuoka, S. Urayama, Y. Kawabe, et al. 1999. Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. The Journal of Laboratory and Clinical Medicine 134: 222-231. (Pubitemid 29423094)
28. Yamamoto, S.,M. Mogi, K. Kinpara, Y. Ishihara, N. Ueda, K. Amano, et al. 1999. Anti-proliferative capsular-like polysaccharide antigen from Actinobacillus actinomycetemcomitans induces apoptotic cell death in mouse osteoblastic MC3T3-E1 cells. Journal of Dental Research 78: 1230-1237. (Pubitemid 32501261)
29. McInnes, I.B., B.P. Leung, R.D. Sturrock, M. Field, and F.Y. Liew. 1997. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nature Medicine 3: 189-195. (Pubitemid 27064704)
30. Carson, W.E., M.E. Ross, R.A. Baiocchi, M.J. Marien, N. Boiani, K. Grabstein, et al. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. The Journal of Clinical Investigation 96: 2578-2582.
31. Schulthess, J., B. Meresse, E. Ramiro-Puig, N. Montcuquet, S. Darche, B. Begue, et al. 2012. Interleukin-15-dependent NKp46+ innate lymphoid cells control intestinal inflammation by recruiting inflammatory monocytes. Immunity 37: 108-121.
32. Kennedy, M.K., M. Glaccum, S.N. Brown, E.A. Butz, J.L. Viney, M. Embers, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. The Journal of Experimental Medicine 191: 771-780.
33. Lodolce, J.P., D.L. Boone, S. Chai, R.E. Swain, T. Dassopoulos, S. Trettin, et al. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9: 669-676. (Pubitemid 28557595)
34. Fehniger, T.A., K. Suzuki, A. Ponnappan, J.B. VanDeusen, M.A. Cooper, S.M. Florea, et al. 2001. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. The Journal of Experimental Medicine 193: 219-231. (Pubitemid 32524453)
35. Ohta, N., T. Hiroi, M.N. Kweon, N. Kinoshita, M.H. Jang, T. Mashimo, et al. 2002. IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta + NK1.1+ T cells for the development of small intestinal inflammation. The Journal of Immunology 169: 460-468. (Pubitemid 34686168)
36. Russell, J.H., and T.J. Ley. 2002. Lymphocyte-mediated cytotoxicity. Annual Review of Immunology 20: 323-370. (Pubitemid 34293428)
37. Hoogduijn, M.J., M. Roemeling-van Rhijn, S.S. Korevaar, A.U. Engela, W. Weimar, and C.C. Baan. 2011. Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies. Human Gene Therapy 22: 1587-1591.
38. Carayol, G., C. Robin, J.H. Bourhis, A. Bennaceur-Griscelli, S. Chouaib, L. Coulombel, et al. 1998. NK cells differentiated frombone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions. European Journal of Immunology 28: 1991-2002. (Pubitemid 28271716)
39. Shikama, Y., M. Yamada, and T. Miyashita. 2003. Caspase-8 and caspase-10 activate NF-kappaB through RIP, NIK and IKKalpha kinases. European Journal of Immunology 33: 1998-2006. (Pubitemid 37120872)
40. Mouratidis, P.X., K.W. Colston, and A.G. Dalgleish. 2007. Doxycycline induces caspase-dependent apoptosis in human pancreatic cancer cells. International Journal of Cancer 120: 743-752. (Pubitemid 46175392)
41. Wang, T., R. Allie, K. Conant, N. Haughey, J. Turchan-Chelowo, K. Hahn, et al. 2006. Granzyme B mediates neurotoxicity through a G-protein-coupled receptor. The FASEB Journal 20: 1209-1211.